Skip to Main Content

Author Details

Scott A Tomlins
Rogel Cancer Center, University of Michigan Medical School ann arbor
2003
252
84
PMIDPaper TitleJournal TitlePublished Year
36385364Antiandrogen Treatment vs Active Surveillance for Patients With Prostate Cancer-Reply.JAMA Oncol2023
37497337Validation of Immunotherapy Response Score as Predictive of Pan-solid Tumor Anti-PD-1/PD-L1 Benefit.Cancer Res Commun2023
37047742Intracellular Zinc Trafficking during <i>Crotalus atrox</i> Venom Wound Development.Int J Mol Sci2023
36750617Development and validation of an integrative pan-solid tumor predictor of PD-1/PD-L1 blockade benefit.Commun Med (Lond)2023
36585434MyProstateScore in men considering repeat biopsy: validation of a simple testing approach.Prostate Cancer Prostatic Dis2023
36828361Highly Recurrent IDH1 Mutations in Prostate Cancer With Psammomatous Calcification.Mod Pathol2023
34753659Association of MyProstateScore (MPS) with prostate cancer grade in the radical prostatectomy specimen.Urol Oncol2022
35708696Enzalutamide Monotherapy vs Active Surveillance in Patients With Low-risk or Intermediate-risk Localized Prostate Cancer: The ENACT Randomized Clinical Trial.JAMA Oncol2022
35504881Alterations in homologous recombination repair genes in prostate cancer brain metastases.Nat Commun2022
33812851Development of a Whole-urine, Multiplexed, Next-generation RNA-sequencing Assay for Early Detection of Aggressive Prostate Cancer.Eur Urol Oncol2022
35220606Comparative genomics of primary prostate cancer and paired metastases: insights from 12 molecular case studies.J Pathol2022
34906585Urinary MyProstateScore (MPS) to Rule out Clinically-Significant Cancer in Men with Equivocal (PI-RADS 3) Multiparametric MRI: Addressing an Unmet Clinical Need.Urology2022
34866317Serial monitoring of genomic alterations in circulating tumor cells of ER-positive/HER2-negative advanced breast cancer: feasibility of precision oncology biomarker detection.Mol Oncol2022
34407969Relevance of pRB Loss in Human Malignancies.Clin Cancer Res2022
32631746Serial Molecular Profiling of Low-grade Prostate Cancer to Assess Tumor Upgrading: A Longitudinal Cohort Study.Eur Urol2021
33547200Virus-positive Merkel Cell Carcinoma Is an Independent Prognostic Group with Distinct Predictive Biomarkers.Clin Cancer Res2021
33727260A Randomized Phase II Study of Androgen Deprivation Therapy with or without Palbociclib in RB-positive Metastatic Hormone-Sensitive Prostate Cancer.Clin Cancer Res2021
34576156Comparative Molecular Analysis of Primary Central Nervous System Lymphomas and Matched Vitreoretinal Lymphomas by Vitreous Liquid Biopsy.Int J Mol Sci2021
34454112Development and Validation of StrataNGS, a Multiplex PCR, Semiconductor Sequencing-Based Comprehensive Genomic Profiling Test.J Mol Diagn2021
34476329Real-World Performance of a Comprehensive Genomic Profiling Test Optimized for Small Tumor Samples.JCO Precis Oncol2021
34198843Molecular Characterization of a Rare Case of Bilateral Vitreoretinal T Cell Lymphoma through Vitreous Liquid Biopsy.Int J Mol Sci2021
34337531Association of Urinary MyProstateScore, Age, and Prostate Volume in a Longitudinal Cohort of Healthy Men: Long-term Findings from the Olmsted County Study.Eur Urol Open Sci2021
33398501[Molecular pathology of urogenital tumors : Recommendations from the 2019 International Society of Urological Pathology (ISUP) Consensus Conference].Pathologe2021
33080150Use of the MyProstateScore Test to Rule Out Clinically Significant Cancer: Validation of a Straightforward Clinical Testing Approach.J Urol2021
33203919TP53 mutations and CDKN2A mutations/deletions are highly recurrent molecular alterations in the malignant progression of sinonasal papillomas.Mod Pathol2021
32371391The role of the histone H3 variant CENPA in prostate cancer.J Biol Chem2020
31789380Histological Characterization of Aldosterone-producing Adrenocortical Adenomas with Different Somatic Mutations.J Clin Endocrinol Metab2020
31969336<i>CDKN1B</i> Deletions are Associated with Metastasis in African American Men with Clinically Localized, Surgically Treated Prostate Cancer.Clin Cancer Res2020
31806642Murine Oviductal High-Grade Serous Carcinomas Mirror the Genomic Alterations, Gene Expression Profiles, and Immune Microenvironment of Their Human Counterparts.Cancer Res2020
32015231A conserved intratumoral regulatory T cell signature identifies 4-1BB as a pan-cancer target.J Clin Invest2020
32044806Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers. I. Molecular Biomarkers in Prostate Cancer.Am J Surg Pathol2020
31983310Somatic <i>CACNA1H</i> Mutation As a Cause of Aldosterone-Producing Adenoma.Hypertension2020
31857679Next-generation sequencing implicates oncogenic roles for p53 and JAK/STAT signaling in microcystic adnexal carcinomas.Mod Pathol2020
31705765Discordant and heterogeneous clinically relevant genomic alterations in circulating tumor cells vs plasma DNA from men with metastatic castration resistant prostate cancer.Genes Chromosomes Cancer2020
33137064Photoacoustic spectral analysis at ultraviolet wavelengths for characterizing the Gleason grades of prostate cancer.Opt Lett2020
32777370Impact of the MyProstateScore (MPS) Test on the Clinical Decision to Undergo Prostate Biopsy: Results From a Contemporary Academic Practice.Urology2020
32576626The MD Anderson Prostate Cancer Patient-derived Xenograft Series (MDA PCa PDX) Captures the Molecular Landscape of Prostate Cancer and Facilitates Marker-driven Therapy Development.Clin Cancer Res2020
32711010Development and Validation of a Deep-learning Model to Assist With Renal Cell Carcinoma Histopathologic Interpretation.Urology2020
32791542Targeted RNAseq of Formalin-Fixed Paraffin-Embedded Tissue to Differentiate Among Benign and Malignant Adrenal Cortical Tumors.Horm Metab Res2020
32844168Prevalence of Somatic Mutations in Aldosterone-Producing Adenomas in Japanese Patients.J Clin Endocrinol Metab2020
32152520Next-generation sequencing identifies recurrent copy number variations in invasive breast carcinomas from Ghana.Mod Pathol2020
32461624Invasive squamous cell carcinomas and precursor lesions on UV-exposed epithelia demonstrate concordant genomic complexity in driver genes.Mod Pathol2020
32540221A genomic survey of sarcomas on sun-exposed skin reveals distinctive candidate drivers and potentially targetable mutations.Hum Pathol2020
29422418Incorporation of Urinary Prostate Cancer Antigen 3 and TMPRSS2:ERG into Prostate Cancer Prevention Trial Risk Calculator.Eur Urol Focus2019
32832835Circulating Tumor Cells as a Predictor of Treatment Response in Clinically Localized Prostate Cancer.JCO Precis Oncol2019
32914029Biologic Significance of Magnetic Resonance Imaging Invisibility in Localized Prostate Cancer.JCO Precis Oncol2019
30119985Managing Nonmetastatic Castration-resistant Prostate Cancer.Eur Urol2019
31266829DNA-Dependent Protein Kinase Drives Prostate Cancer Progression through Transcriptional Regulation of the Wnt Signaling Pathway.Clin Cancer Res2019
31276932Circulating Tumor Cell-Based Molecular Classifier for Predicting Resistance to Abiraterone and Enzalutamide in Metastatic Castration-Resistant Prostate Cancer.Neoplasia2019
30739536Genetic Characteristics of Aldosterone-Producing Adenomas in Blacks.Hypertension2019
  • 1 - 50 of 252

Recommended Authors

Yang Liu
Veracyte inc.
Career Start Year 2019
Number of shared co-authors 56
Rohan Bareja
Case Western Reserve University
Career Start Year 2017
Number of shared co-authors 40
Michael Sigouros
Caryl and Israel Englander Institute for Precision Medicine
Career Start Year 2017
Number of shared co-authors 32
Vincent Huang
Ontario Institute for Cancer Research
Career Start Year 2016
Number of shared co-authors 14
Wei Yuan
The Institute for Cancer Research
Career Start Year 2015
Number of shared co-authors 46
Travis Gerke
The Prostate Cancer Clinical Trials Consortium
Career Start Year 2014
Number of shared co-authors 38
Niedzica Camacho
Memorial Sloan Kettering Cancer Center
Career Start Year 2013
Number of shared co-authors 12
Martina Kluth
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Career Start Year 2012
Number of shared co-authors 0
Julie Livingstone
University of California los angeles
Career Start Year 2011
Number of shared co-authors 36
Adam G Sowalsky
National Cancer Institute
Career Start Year 2010
Number of shared co-authors 27
Anne Haegert
University of British Columbia
Career Start Year 2008
Number of shared co-authors 30
Verena Sailer
Institute for Pathology, University Hospital Schleswig-Holstein
Career Start Year 2007
Number of shared co-authors 38
Mark M Pomerantz
Dana-Farber Cancer Institute
Career Start Year 2007
Number of shared co-authors 59
Christina M??ller-Koop
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Career Start Year 2006
Number of shared co-authors 2
Roula Albadine
Centre hospitalier de l'Universite de Montreal
Career Start Year 2006
Number of shared co-authors 12
Alok K Tewari
Dana-Farber Cancer Institute, Harvard Medical School
Career Start Year 2005
Number of shared co-authors 12
Mitchell G Lawrence
Biomedicine Discovery Institute, Monash University
Career Start Year 2005
Number of shared co-authors 6
Thorsten Schlomm
Charite - University Hospital Berlin
Career Start Year 2004
Number of shared co-authors 27
Nening Dennis
Institute of Cancer Research
Career Start Year 2004
Number of shared co-authors 7
Robert H Bell
University of British Columbia
Career Start Year 2004
Number of shared co-authors 25
Adam Sharp
The Institute for Cancer Research
Career Start Year 2003
Number of shared co-authors 45
Anne Y Warren
Cambridge University Hospitals National Health Service Foundation Trust
Career Start Year 2003
Number of shared co-authors 13
Ladan Fazli
University of British Columbia
Career Start Year 2002
Number of shared co-authors 67
Michael Fraser
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2001
Number of shared co-authors 57
Yuzhuo Wang
University of British Columbia
Career Start Year 2000
Number of shared co-authors 76
Hayley C Whitaker
University College London
Career Start Year 1999
Number of shared co-authors 13
Claudia Hube-Magg
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Career Start Year 1997
Number of shared co-authors 0
Gyorgy Petrovics
Henry Jackson Foundation for the Advancement of Military Medicine (HJF)
Career Start Year 1990
Number of shared co-authors 26
George Steven Bova
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year 1982
Number of shared co-authors 29
Jeffrey S Ross
Foundation Medicine
Career Start Year 1974
Number of shared co-authors 29

Collaborators

Arul M Chinnaiyan
University of Michigan Medical School.
Co-authored papers 122
Rohit Mehra
Michigan Center for Translational Pathology.
Co-authored papers 65
Javed Siddiqui
Michigan Center for Translational Pathology, University of Michigan ann arbor
Co-authored papers 54
Mark A Rubin
University of Bern
Co-authored papers 45
Daniel H Hovelson
Michigan Center for Translational Pathology, University of Michigan ann arbor
Co-authored papers 43
Lakshmi P Kunju
Michigan Center for Translational Pathology, University of Michigan ann arbor
Co-authored papers 39
Felix Y Feng
UCSF Medical Center-Mount Zion
Co-authored papers 37
Todd M Morgan
University of Michigan ann arbor
Co-authored papers 34
Xuhong Cao
Michigan Center for Translational Pathology.
Co-authored papers 32
Sooryanarayana Varambally
University of Alabama at Birmingham, USA O'Neal Comprehensive Cancer Center
Co-authored papers 32
Nallasivam Palanisamy
Vattikuti Urology Institute
Co-authored papers 29
Robert J Lonigro
Michigan Center for Translational Pathology, University of Michigan ann arbor
Co-authored papers 25
Kenneth J Pienta
The Brady Urological Institute, Johns Hopkins University School of Medicine
Co-authored papers 25
Daniel E Spratt
University Hospitals Seidman Cancer Center, Case Western Reserve University
Co-authored papers 21
Saravana M Dhanasekaran
Co-authored papers 20
Dan R Robinson
Michigan Center for Translational Pathology, University of Michigan ann arbor
Co-authored papers 16
Simpa S Salami
University of Michigan Medical School ann arbor
Co-authored papers 16
Jeffrey J Tosoian
Vanderbilt University Medical Center
Co-authored papers 13
Yi-Mi Wu
University of Michigan Medical School ann arbor
Co-authored papers 12
Edward M Schaeffer
Northwestern University Feinberg School of Medicine
Co-authored papers 12
Francesca Demichelis
University of Trento
Co-authored papers 11
Jianjun Yu
Co-authored papers 11
Thomas J Giordano
University of Michigan ann arbor
Co-authored papers 10
Chandan Kumar-Sinha
Co-authored papers 9
Robert Jeffrey Karnes
Mayo Clinic
Co-authored papers 9
Juan Miguel Mosquera
Caryl and Israel Englander Institute for Precision Medicine
Co-authored papers 9
Tamara L Lotan
Johns Hopkins University School of Medicine
Co-authored papers 9
Kathleen A Cooney
Duke University School of Medicine, and the Duke Cancer Institute
Co-authored papers 9
Tobias Else
Harvard Medical School
Co-authored papers 8
Maha Hussain
Northwestern University
Co-authored papers 8
Release 1.2